Search
Now showing items 1-4 of 4
Recombinant vaccine for porcine pleuropneumonia
(United States. Patent and Trademark Office, 1998-09-08)
This invention discloses the DNA sequences coding for the Actinobacillus pleuropneumonia hemolysin(s). It further discloses a method of producing the A. pleuropneumoniae hemolysin(s) from recombinant cells. It also provides ...
Vaccine comprising Brucella abortus which has O polysaccharide antigen absent
(United States. Patent and Trademark Office, 1998-02-17)
The present invention is an improved vaccine against Brucella abortus which permits differentiation between vaccinated and field strain infected cattle. The vaccine can be administered in two different forms: (1) cell ...
MHC II analog from Staphylococcus aureus
(United States. Patent and Trademark Office, 1997-07-15)
Staphylococcus aureus can bind a number of different extracellular matrix proteins. Recent studies have shown that one particular Staphylococcus protein has the capacity of binding several different matrix proteins. The ...
Decorin binding protein compositions and methods of use
(United States. Patent and Trademark Office, 1998-12-29)
Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...